Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for Hydroxocobalamin Injection.

14/01/2025

GMT Eight

ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Mecobalamin Injection. Mecobalamin Injection is indicated for the treatment of peripheral neuropathy and megaloblastic anemia caused by vitamin B12 deficiency.

Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for amlodipine benzenesulfonate tablets

Chalkis Health Industry (000972.SZ) plans to raise funds for the acquisition of related matters, trading suspended from January 14th.

Contact: contact@gmteight.com

Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for Hydroxocobalamin Injection.

RECOMMEND

On the eve of Trump's return, traders increased their bets on a strong dollar to the highest level since 2019.

Is it time to sell the dollar and buy treasury bonds? Morgan Stanley: There is a high likelihood of the Fed cutting interest rates in March.

The U.S. FTC approves Chevron Corporation's $53 billion acquisition of Hess Corporation. Challenge from Exxon Mobil Corporation remains unresolved.